Bioavailability and pharmacokinetics of dehydroepiandrosterone in the cynomolgus monkey

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 9, 2003, Pages 4293-4302

  Leblanc, Mathias ^a   Labrie, Claude ^a   Bélanger, Alain ^a   Candas, Bernard ^a   Labrie, Fernand ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIONE; ANDROSTERONE; DEXAMETHASONE; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG HALF LIFE; FEMALE; HORMONE RELEASE; HYDROCORTISONE BLOOD LEVEL; MONKEY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEROID BLOOD LEVEL;

ANIMALIA; MACACA FASCICULARIS;

EID: 0141676001     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-022012     Document Type: Article

References (40)

1. Labrie F, Luu-The V, Labrie C, Simard J 2001 DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front Neuroendocrinol 22:185-212
2. Judd HL, Lucas WE, Yen SS 1974 Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 118:793-798
3. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:C113-C118
4. Labrie F, Bélanger A, Simard J, Labrie C, Lin S, Pelletier G 2003 Sources and roles of androgens in women - inhibition of breast cancer by androgens and DHEA. Endocr Rev 24:152-182
5. Orentreich N, Brind JL, Rizer RL, Vogelman JH 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555
6. Sulcova J, Hill M, Hampl R, Starka L 1997 Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J Endocrinol 154:57-62
7. Labrie F, Belanger A, Cusan L, Gomez JL, Candas B 1997 Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 82:2396-2402
8. Belanger A, Candas B, Dupont A, Cusan L, Diamond P, Gomez JL, Labrie F 1994 Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab 79:1086-1090
9. Zwain IH, Yen SS 1999 Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 140:880-887
10. Svec F, Porter JR 1998 The actions of exogenous dehydroepiandrosterone in experimental animals and humans. Proc Soc Exp Biol Med 218:174-191
11. Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B 1997 Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498-3505
12. Baulieu EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharriere O, Nouveau S, Rakoto-Ailson B, Souberblelle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X, Forette F 2000 Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA 97:4279-4284
13. Diamond P, Cusan L, Gomez JL, Belanger A, Labrie F 1996 Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J Endocrinol 150(Suppl):S43-S50
14. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B 1999 Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020
15. Yanase T, Fukahori M, Taniguchi S, Nishi Y, Sakai Y, Takayanagi R, Haji M, Nawata H 1996 Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia. Endocr J 43:119-123
16. Bastianetto S, Ramassamy C, Poirier J, Quirion R 1999 Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 66:35-41
17. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H 1997 Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 41:311-318
18. Baulieu EE 1998 Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 23:963-987
19. Davis SR 1999 The therapeutic use of androgens in women. J Steroid Biochem Mol Biol 69:177-184
20. Fuller GB, Hobson WC, Reyes FI, Winter JS, Faiman C 1984 Influence of restraint and ketamine anesthesia on adrenal steroids, progesterone, and gonadotropins in rhesus monkeys. Proc Soc Exp Biol Med 175:487-490
21. Bellino FL, Wise PM 2003 Nonhuman primate models of menopause workshop. Biol Reprod 68:10-18
22. Meusy-Dessolle N, Dang DC 1985 Plasma concentrations of testosterone, dihydrotestosterone, δ 4-androstenedione, dehydroepiandrosterone and oestradiol-17β in the crab-eating monkey (Macaca fascicularis) from birth to adulthood. J Reprod Fertil 74:347-359
23. Guillemette C, Hum DW, Belanger A 1996 Levels of plasma C19 steroids and 5 α-reduced C19 steroid glucuronides in primates, rodents, and domestic animals. Am J Physiol 271:E348-E353
24. Legrain S, Massien C, Lahlou N, Roger M, Debuire B, Diquet B, Chatellier G, Azizi M, Faucounau V, Porchet H, Forette F, Baulieu EE 2000 Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 85:3208-3217
25. Arlt W, Justl HG, Callies F, Reincke M, Hubler D, Oettel M, Ernst M, Schulte HM, Allolio B 1998 Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J Clin Endocrinol Metab 83:1928-1934
26. Haning Jr RV, Austin CW, Carlson IH, Kuzma DL, Zweibel WJ 1985 Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis. Obstet Gynecol 65:199-205
27. Couzinet B, Meduri G, Lecce MG, Young J, Brailly S, Loosfelt H, Milgrom E, Schaison G 2001 The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 86:5060-5066
28. Arlt W, Martens JW, Song M, Wang JT, Auchus RJ, Miller WL 2002 Molecular evolution of adrenarche: structural and functional analysis of p450c17 from four primate species. Endocrinology 143:4665-4672
29. Longcope C 1995 Metabolism of dehydroeplandrosterone. Ann NY Acad Sci 774:143-148
30. Longcope C, Tast J 1996 Dehydroepiandrosterone metabolism in the female rhesus monkey: oral versus intravenous administration. Steroids 61:7-10
31. Frye RF, Kroboth PD, Kroboth FJ, Stone RA, Folan M, Salek FS, Pollock BG, Linares AM, Hakala C 2000 Sex differences in the pharmacokinetics of dehydroepiandrosterone (DHEA) after single- and multiple-dose administration in healthy older adults. J Clin Pharmacol 40:596-605
32. Valenti G, Banchini A, Denti L, Maggio M, Ceresini G, Ceda GP 1999 Acute oral administration of dehydroepiandrosterone in male subjects: effect of age on bioavailability, sulfoconjugation and bioconversion in other steroids. J Endocrinol Invest 22:24-28
33. Buster JE, Casson PR, Straughn AB, Dale D, Umstot ES, Chiamori N, Abraham GE 1992 Postmenopausal steroid replacement with micronized dehydroepiandrosterone: preliminary oral bioavailability and dose proportionality studies. Am J Obstet Gynecol 166:1163-1168; discussion 1168-1170
34. Rittmaster RS 1993 Androgen conjugates: physiology and clinical significance. Endocr Rev 14:121-132
35. Albert C, Barbier O, Vallee M, Beaudry G, Belanger A, Hum DW 2000 Distribution of uridine diphosphate-glucuronosyltransferase (UGT) expression and activity in cynomolgus monkey tissues: evidence for differential expression of steroid-conjugating UGT enzymes in steroid target tissues. Endocrinology 141:2472-2480
36. Casson PR, Straughn AB, Umstot ES, Abraham GE, Carson SA, Buster JE 1996 Delivery of dehydroepiandrosterone to premenopausal women: effects of micronization and nonoral administration. Am J Obstet Gynecol 174:649-653
37. Luu-The V, Bernier F, Dufort I 1996 Steroid sulfotransferases. J Endocrinol 150(Suppl):S87-S97
38. Arlt W, Haas J, Callies F, Reincke M, Hubler D, Oettel M, Ernst M, Schulte HM, Allolio B 1999 Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. J Clin Endocrinol Metab 84:2170-2176
39. Morales AJ, Nolan JJ, Nelson JC, Yen SS 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 78:1360-1367
40. Labrie F, Belanger A, Cusan L, Candas B 1997 Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 82:2403-2409